Cardiology Letters 2017, 26(4):228-235
Prognosis of heart failure with preserved ejection fraction and heart failure with reduced ejection fraction in 3-years follow up: A comparative analysis
- 1 Oddelenia všeobecnej kardiológie, Národný ústav srdcových a cievnych chorôb a. s., Bratislava
- 2 Oddelenia neinvazívnej kardiológie, IV. interná klinika, Nemocnica sv. Cyrila a Metoda, Bratislava
- 3 IV. interná kliniky, Nemocnica sv. Cyrila a Metoda, Bratislava, Slovenská republika
Background: Data related to heart failure with preserved ejection fraction (HFPEF) are limited, even though the prevalence is high. Compared to heart failure with reduced ejection fraction (HFREF), prognosis is similarly poor.
Objective: The main objective of this monocentric study is to evaluate mortality and prognosis of patients with HFPEF in 3-years follow up.
Methods: A total of 109 consecutive patients (HFPEF: n=63 a HFREF: n=46) hospitalized for HF in internal department were included. They were divided into two groups: HFPEF with EF > 40% and HFREF with LVEF ≤ 40%. Each patient underwent complex examination every 6 months for 3 years.
Results: All-cause and cardiovascular mortality were similar in HFPEF vs. HFREF in 3-years follow up (35% vs. 37%, p = NS and 64% vs. 59%, p = NS, respectively). Likewise, the rate of rehospitalisation for heart failure (HF) was similar in HFPEF vs. HFREF (30% vs. 37%, p = NS, respectively). A dysfunctional right ventricle (RV) was significantly more prevalent in deceased patients with HFPEF compared to those with HFREF (40.9% vs. 17.1%, p<0.05). We also observed a trend to significantly higher level of NT-proBNP in deceased patients with HFPEF compared to patients with HFREF (4204 vs. 2622 ng/ml, p=0.059). We identified the following parameters as independent predictors of survival in HFPEF: preserved RV function (HR 0.33 95% CI 0.13-0.83, p<0.05), NT-proBNP (HR 1.007 per 100 ng/l 95% CI 1.002-1.0123, p<0.01) and BMI (HR 1.16 per 1 kg/m2 95% CI 1.06-1.27, p<0.01).
Conclusion: We did not identify any significant differences regarding 3-years all-cause and cardiovascular mortality in HFPEF compared to HFREF. The rate of rehospitalisation for HF in HFPEF vs. HFREF was also nonsignificant different. We identified preserved RV function, NT-proBNP and BMI as the main independent predictors of survival in HFPEF.
Keywords: heart failure with preserved ejection fraction; prognosis; preserved right ventricular ejection fraction; BMI; NT-proBNP
Published: April 1, 2017 Show citation
| ACS | AIP | APA | ASA | Harvard | Chicago | Chicago Notes | IEEE | ISO690 | MLA | NLM | Turabian | Vancouver |
References
- Bhatia RS, Tu JV, Lee D, et al. Outcome of heart failure with preserved ejection fraction in a population-based study. N Engl J Med 2006;355:260-269.
Go to original source... - Nagueh SF, Appleton CP, Gillebert TC, et al. Recommendations for the evaluation of left ventricular diastolic function by echocardiography. Eur J Echocardiogr 2009;10:165-193.
Go to original source... - Meluzin J, Spinarova L, Dusek L, et al. Prognostic importance of the right ventricular function assessed by Doppler tissue imaging. Eur J Echocardiography 2003;4:262-271.
Go to original source... - Rudski LG, Lai WW, Afilalo J, et al. Guidelines for the Echocardiographic Assessment of the Right Heart in Adults: A Report from the American Society of Echocardiography Endorsed by the European Association of Echocardiography, a registered branch of the European Society of Cardiology, and the Canadian Society of Echocardiography. J Am SocEchocardiogr 2010;23:685-713.
Go to original source... - Owan TE, Hodge DO, Herges RM, et al. Trends in prevalence and outcome of heart failure with preserved ejection fraction. N Engl J Med 2006;355:251-259.
Go to original source... - Massie BM, Carson PE, McMurray JJ, et al. Irbesartan in patients with heart failure and preserved ejection fraction. N Engl J Med 2008;359:2456-2467.
Go to original source... - Chan MMY, Lam CSP. How do patients with heart failure with preserved ejection fraction die? Eur J Heart fail 2013;15:604613.
Go to original source... - Rickenbacher P, Pfisterer M, Burkard T, et al. Why and how do elderly patients with heart failure die? Insights from the TIMECHF study. Eur J Heart Fail 201214:1218-1229.
Go to original source... - Lenzen MJ, Scholte OP, Reimer WJ, et al. Differences between patients with a preserved and a depressed left ventricular function: a report from the EuroHeart Failure Survey. Eur Heart J 2004;25:1214-1220.
Go to original source... - Ponikowski P, Voors AA, Anker SD, et al. 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC) Developed with the special contribution of the Heart Failure Association (HFA) of the ESC. Eur Heart J 2016;37:2129-2200.
Go to original source... - Douglas PS, Garcia MJ, Haines DE, et al. ACCF/ASE/AHA/ASNC/ HFSA/HRS/SCAI/SCCM/SCCT/SCMR 2011 Appropriate Use Criteria for Echocardiography. A Report of the American College of Cardiology Foundation Appropriate Use Criteria Task Force; American Society of Echocardiography; American Heart Association; American Society of Nuclear Cardiology; Heart Failure Society of America; Heart Rhythm Society; Society for Cardiovascular Angiography and Interventions; Society of Critical Care Medicine; Society of Cardiovascular Computed Tomography; Society for Cardiovascular Magnetic Resonance; American College of Chest Physicians. J Am Soc Echocardiogr 2011;24:229-267.
Go to original source... - Nagueh SF, Appleton CP, Gillebert TC, et al. Recommendations for the evaluation of left ventricular diastolic function by echocardiography. Eur J Echocardiogr 2009;10:165-193.
Go to original source... - Meluzin J, Spinarova L, Dusek L, et al. Prognostic importance of the right ventricular function assessed by Doppler tissue imaging. Eur J Echocardiography 2003;4:262-271.
Go to original source... - Rudski LG, Lai WW, Afilalo J, et al. Guidelines for the Echocardiographic Assessment of the Right Heart in Adults: A Report from the American Society of Echocardiography Endorsed by the European Association of Echocardiography, a registered branch of the European Society of Cardiology, and the Canadian Society of Echocardiography. J Am Soc Echocardiogr 2010;23:685-713.
Go to original source... - Owan TE, Hodge DO, Herges RM, et al. Trends in prevalence and outcome of heart failure with preserved ejection fraction. N Engl J Med 2006;355:251-259.
Go to original source... - Massie BM, Carson PE, McMurray JJ, et al. Irbesartan in patients with heart failure and preserved ejection fraction. N Engl J Med 2008;359: 456-2467.
Go to original source... - Chan MMY, Lam CSP. How do patients with heart failure with preserved ejection fraction die? Eur J Heart fail 2013;15:604613.
Go to original source... - Rickenbacher P, Pfisterer M, Burkard T, et al. Why and how do elderly patients with heart failure die? Insights from the TIMECHF study. Eur J Heart Fail 2012;14:1218-1229.
Go to original source... - Lenzen MJ, Scholte OP, Reimer WJ, et al. Differences between patients with a preserved and a depressed left ventricular function: a report from the EuroHeart Failure Survey. Eur Heart J 2004;25:1214-1220.
Go to original source... - Olsson LG, Swedberg K, Ducharme A, et al. Atrial fibrillation and risk of clinical events in chronic heart failure with and without left ventricular systolic dysfunction: results from the Candesartan in Heart failure-Assessment of Reduction in Mortality and morbidity (CHARM) program. J Am CollCardiol 2006;47:1997-2004.
Go to original source... - Linssen GCM, Rienstra M, Jaarsma T, et al. Clinical and prognostic effects of atrial fibrillation in heart failure patients with reduced and preserved left ventricular ejection fraction. Eur J Heart Fail 2011;13:1111-1120.
Go to original source... - Fonarow GC, Peacock WF, Phillips CO, et al. Admission B-type natriuretic peptide levels and in-hospital mortality in acute decompensated heart failure. J Am Coll Cardiol 2007;49:19431950.
Go to original source... - DeFilippi CR, Christensen RH, Kop WJ, et al. Left ventricular ejection fraction assessment in older adults: an adjunct to natriuretic peptide testing to identify risk of new-onset heart failure and cardiovascular death? J Am Coll Cardiol 2011;58:1497-1506.
Go to original source... - Oreopoulos A, Padwal R, Kalantar-Zadeh K, et al. Body mass index and mortality in heart failure: a meta-analysis. Am Heart J 2008;156:13-22.
Go to original source... - Lavie CJ, Alpert MA, Arena R, et al. Impact of obesity and the obesity paradox on prevalence and prognosis in heart failure. JACC Heart Fail 2013;1:93-102.
Go to original source... - Ather S, Chan W, Bozkurt B, et al. Impact of noncardiac comorbidities on morbidity and mortality in a predominantly male population with heart failure and preserved versus reduced ejection fraction. J Am Coll Cardiol 2012;59:998-1005.
Go to original source... - Kapoor JR, Heidenreich PA. Obesity and survival in patients with heart failure and preserved systolic function: a U-shaped relationship. Am Heart J 2010;159:75-80.
Go to original source... - Gustafsson F, Kragelund CB, Torp-Pedersen C, et al. Effect of obesity and being overweight on long-term mortality in congestive heart failure: influence of left ventricular systolic function. Eur Heart J 2005;26:58-64.
Go to original source... - Ferreira I, Stehouwer CDA. Obesity paradox or inappropriate study designs? Time for life-course epidemiology. J Hypertens 2012;30:2271-2275.
Go to original source... - Banack HR, Kaufman JS. The 'Obesity Paradox' Explained. Epidemiology 2013;24:461-462.
Go to original source... - Chrysant SG, Chrysant GS. New insights into the true nature of the obesity paradox and the lower cardiovascular risk. J Am Soc Hypertens. 2013;7:85-94.
Go to original source... - Pozzo J, Fournier P, Lairez O, et al. Obesity Paradox: Origin and best way to assess severity in patients with systolic HF. Obesity, 2015;23:2002-2008.
Go to original source... - O'Connor CM, Gattis WA, Shaw L, et al. Clinical characteristics and long-term outcomes of patients with heart failure and preserved systolic function. Am J Cardiol 2000;86:863-867.
Go to original source... - Hogg K, Swedberg K, McMurray J. Heart failure with preserved left ventricular systolic function; epidemiology, clinical characteristics, and prognosis. J Am Coll Cardiol 2004;43:317-327.
Go to original source... - Puwanant S, Priester TC, Mookadam F, et al. Right ventricular function in patients with preserved and reduced ejection fraction heart failure. Eur J Echocardiogr 2009;10:733-737.
Go to original source... - Luo C, Ramachandran D, Ware D, et al. Modeling left ventricular diastolic dysfunction: classification and key indicators. Theor Biol Med Model 2011;8:14.
Go to original source... - Ghio S, Recusani F, Klersy C, et al. Prognostic usefulness of the tricuspid annular plane systolic excursion in patients with congestive heart failure secondary to idiopathic or ischemic dilated cardiomyopathy. Am J Cardiol 2000;85:837-842.
Go to original source... - Dokainish H, Sengupta R, Patel R, et al. Usefulness of Right Ventricular Tissue Doppler Imaging to Predict Outcome in Left Ventricular Heart Failure Independent of Left Ventricular Diastolic Function. Am J Cardiol 2007;99:961-965.
Go to original source... - Damy T, Viallet C, Lairez O, et al. Comparison of four right ventricular systolic echocardiographic parameters to predict adverse outcomes in chronic heart failure. Eur J Heart Fail 2009;11:818-824.
Go to original source...

